Cargando…
SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma
Overdue treatment and prognostic evaluation lead to low survival rates in patients with lung adenocarcinoma (LUAD). To date, effective biomarkers for prognosis are still required. The aim of the present study was to screen differentially expressed genes (DEGs) as biomarkers for prognostic evaluation...
Autores principales: | Zhang, Weiguo, Fan, Junli, Chen, Qiang, Lei, Caipeng, Qiao, Bin, Liu, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962856/ https://www.ncbi.nlm.nih.gov/pubmed/29849788 http://dx.doi.org/10.3892/ol.2018.8235 |
Ejemplares similares
-
Infelix Ager
por: King, W. G.
Publicado: (1913) -
AGER rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinoma
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2017) -
The Physiology Constant Database of Teen-Agers in Beijing
por: Wei-Qi, Wei, et al.
Publicado: (2004) -
AGER promotes proliferation and migration in cervical cancer
por: Zhu, Xuejie, et al.
Publicado: (2018) -
Comments about SuperAging and SuperAgers
por: Goldberg, Terry E.
Publicado: (2019)